Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies

Standard

Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. / Escher, Felicitas; Pietsch, Heiko; Aleshcheva, Ganna; Bock, Thomas; Baumeier, Christian; Elsaesser, Albrecht; Wenzel, Philip; Hamm, Christian; Westenfeld, Ralph; Schultheiss, Maximilian; Gross, Ulrich; Morawietz, Lars; Schultheiss, Heinz-Peter.

in: ESC HEART FAIL, Jahrgang 7, Nr. 5, 10.2020, S. 2440-2447.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Escher, F, Pietsch, H, Aleshcheva, G, Bock, T, Baumeier, C, Elsaesser, A, Wenzel, P, Hamm, C, Westenfeld, R, Schultheiss, M, Gross, U, Morawietz, L & Schultheiss, H-P 2020, 'Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies', ESC HEART FAIL, Jg. 7, Nr. 5, S. 2440-2447. https://doi.org/10.1002/ehf2.12805

APA

Escher, F., Pietsch, H., Aleshcheva, G., Bock, T., Baumeier, C., Elsaesser, A., Wenzel, P., Hamm, C., Westenfeld, R., Schultheiss, M., Gross, U., Morawietz, L., & Schultheiss, H-P. (2020). Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC HEART FAIL, 7(5), 2440-2447. https://doi.org/10.1002/ehf2.12805

Vancouver

Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC HEART FAIL. 2020 Okt;7(5):2440-2447. https://doi.org/10.1002/ehf2.12805

Bibtex

@article{a1dccf1eb4ec4c24a06362225b5be67f,
title = "Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies",
abstract = "AIMS: Since December 2019, the novel coronavirus SARS-CoV-2 has spread rapidly throughout China and keeps the world in suspense. Cardiovascular complications with myocarditis and embolism due to COVID-19 have been reported. SARS-CoV-2 genome detection in the heart muscle has not been demonstrated so far, and the underlying pathophysiological mechanisms remain to be investigated.METHODS AND RESULTS: Endomyocardial biopsies (EMBs) of 104 patients (mean age: 57.90 ± 16.37 years; left ventricular ejection fraction: 33.7 ± 14.6%, sex: n = 79 male/25 female) with suspected myocarditis or unexplained heart failure were analysed. EMB analysis included histology, immunohistochemistry, and detection of SARS-CoV-2 genomes by real-time reverse transcription polymerase chain reaction in the IKDT Berlin, Germany. Among 104 EMBs investigated, five were confirmed with SARS-CoV-2 infected by reverse real-time transcriptase polymerase chain reaction. We describe patients of different history of symptoms and time duration. Additionally, we investigated histopathological changes in myocardial tissue showing that the inflammatory process in EMBs seemed to permeate vascular wall leading to small arterial obliteration and damage.CONCLUSIONS: This is the first report that established the evidence of SARS-CoV-2 genomes detection in EMBs. In these patients, myocardial injury ischaemia may play a role, which could explain the ubiquitous troponin increases. EMB-based identification of the cause of myocardial injury may contribute to explain the different evolution of complicated SARS-CoV-2-infection and to design future specific and personalized treatment strategies.",
author = "Felicitas Escher and Heiko Pietsch and Ganna Aleshcheva and Thomas Bock and Christian Baumeier and Albrecht Elsaesser and Philip Wenzel and Christian Hamm and Ralph Westenfeld and Maximilian Schultheiss and Ulrich Gross and Lars Morawietz and Heinz-Peter Schultheiss",
note = "{\textcopyright} 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.",
year = "2020",
month = oct,
doi = "10.1002/ehf2.12805",
language = "English",
volume = "7",
pages = "2440--2447",
journal = "ESC HEART FAIL",
issn = "2055-5822",
publisher = "The Heart Failure Association of the European Society of Cardiology",
number = "5",

}

RIS

TY - JOUR

T1 - Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies

AU - Escher, Felicitas

AU - Pietsch, Heiko

AU - Aleshcheva, Ganna

AU - Bock, Thomas

AU - Baumeier, Christian

AU - Elsaesser, Albrecht

AU - Wenzel, Philip

AU - Hamm, Christian

AU - Westenfeld, Ralph

AU - Schultheiss, Maximilian

AU - Gross, Ulrich

AU - Morawietz, Lars

AU - Schultheiss, Heinz-Peter

N1 - © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

PY - 2020/10

Y1 - 2020/10

N2 - AIMS: Since December 2019, the novel coronavirus SARS-CoV-2 has spread rapidly throughout China and keeps the world in suspense. Cardiovascular complications with myocarditis and embolism due to COVID-19 have been reported. SARS-CoV-2 genome detection in the heart muscle has not been demonstrated so far, and the underlying pathophysiological mechanisms remain to be investigated.METHODS AND RESULTS: Endomyocardial biopsies (EMBs) of 104 patients (mean age: 57.90 ± 16.37 years; left ventricular ejection fraction: 33.7 ± 14.6%, sex: n = 79 male/25 female) with suspected myocarditis or unexplained heart failure were analysed. EMB analysis included histology, immunohistochemistry, and detection of SARS-CoV-2 genomes by real-time reverse transcription polymerase chain reaction in the IKDT Berlin, Germany. Among 104 EMBs investigated, five were confirmed with SARS-CoV-2 infected by reverse real-time transcriptase polymerase chain reaction. We describe patients of different history of symptoms and time duration. Additionally, we investigated histopathological changes in myocardial tissue showing that the inflammatory process in EMBs seemed to permeate vascular wall leading to small arterial obliteration and damage.CONCLUSIONS: This is the first report that established the evidence of SARS-CoV-2 genomes detection in EMBs. In these patients, myocardial injury ischaemia may play a role, which could explain the ubiquitous troponin increases. EMB-based identification of the cause of myocardial injury may contribute to explain the different evolution of complicated SARS-CoV-2-infection and to design future specific and personalized treatment strategies.

AB - AIMS: Since December 2019, the novel coronavirus SARS-CoV-2 has spread rapidly throughout China and keeps the world in suspense. Cardiovascular complications with myocarditis and embolism due to COVID-19 have been reported. SARS-CoV-2 genome detection in the heart muscle has not been demonstrated so far, and the underlying pathophysiological mechanisms remain to be investigated.METHODS AND RESULTS: Endomyocardial biopsies (EMBs) of 104 patients (mean age: 57.90 ± 16.37 years; left ventricular ejection fraction: 33.7 ± 14.6%, sex: n = 79 male/25 female) with suspected myocarditis or unexplained heart failure were analysed. EMB analysis included histology, immunohistochemistry, and detection of SARS-CoV-2 genomes by real-time reverse transcription polymerase chain reaction in the IKDT Berlin, Germany. Among 104 EMBs investigated, five were confirmed with SARS-CoV-2 infected by reverse real-time transcriptase polymerase chain reaction. We describe patients of different history of symptoms and time duration. Additionally, we investigated histopathological changes in myocardial tissue showing that the inflammatory process in EMBs seemed to permeate vascular wall leading to small arterial obliteration and damage.CONCLUSIONS: This is the first report that established the evidence of SARS-CoV-2 genomes detection in EMBs. In these patients, myocardial injury ischaemia may play a role, which could explain the ubiquitous troponin increases. EMB-based identification of the cause of myocardial injury may contribute to explain the different evolution of complicated SARS-CoV-2-infection and to design future specific and personalized treatment strategies.

U2 - 10.1002/ehf2.12805

DO - 10.1002/ehf2.12805

M3 - SCORING: Journal article

C2 - 32529795

VL - 7

SP - 2440

EP - 2447

JO - ESC HEART FAIL

JF - ESC HEART FAIL

SN - 2055-5822

IS - 5

ER -